Clinical study
Impaired left atrial mechanical function after cardioversion: Relation to the duration of atrial fibrillation

https://doi.org/10.1016/0735-1097(94)90652-1Get rights and content
Under a Creative Commons license
open archive

Abstract

Objectives. We hypothesized that the time course of the recovery of atrial systolic function may be related to the duration of atrial fibrillation before cardioversion and sought to study noninvesively the recovery of left atrial mechanical function utilizing serial transthoracic Doppler studies.

Background. Recovery of atrial mechanical function may be delayed for several weeks after successful cardioversion of atrial fibrillation to sinus rhythm.

Methods. After successful cardioversion, 60 patients with atrial fibrillation of brief (≤2 week, 17 patients), moderate (>2 to 6 weeks, 22 patients) or prolonged (>6 weeks, 21 patients) duration were followed up with serial transmitral pulsed Doppler echocardiography immediately (60 patients) and at 24 h (45 patients), 1 week (41 patients), 1 month (31 patients) and >3 months (30 patients) after cardioversion.

Results. Atrial mechanical function is greater immediately and at 24 h and 1 week after cardioversion in patients with “brief” compared with “prolonged” atrial fibrillation. In all groups, atrial mechanical function increases over time, ultimately achieving similar levels. Full recovery of atrial mechanical function, however, is achieved within 24 h in patients with brief atrial fibrillation, within 1 week in patients with moderate-duration atrial fibrillation and within 1 month in patients with prolonged atrial fibrillation.

Conclusions. Recovery of left atrial mechanical function is related to the duration of atrial fibrillation before cardioversion. These findings have important implications for assessing the early hemodynamic benefit of successful cardioversion.

Cited by (0)

1

Dr. Manning is supported in part by a Physician-Scientist Award from the National Institute on Aging (AG00294), National Institutes of Health, Bethesda, Maryland, and the Edward Mallinckrodt, Jr. Foundation, St. Louis, Missouri.

2

Dr. Silverman is supported in part by a Young Investigator Award from the Patrick and Katherine Weldon Donahue Foundation, Hartford, Connecticut.